For: | Siramolpiwat S. Transjugular intrahepatic portosystemic shunts and portal hypertension-related complications. World J Gastroenterol 2014; 20(45): 16996-17010 [PMID: 25493012 DOI: 10.3748/wjg.v20.i45.16996] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v20/i45/16996.htm |
Number | Citing Articles |
1 |
Brandon C. Perry, Sharon W. Kwan. Portosystemic Shunts: Stable Utilization and Improved Outcomes, Two Decades After the Transjugular Intrahepatic Portosystemic Shunt. Journal of the American College of Radiology 2015; 12(12): 1427 doi: 10.1016/j.jacr.2015.06.037
|
2 |
Susanne Feder, Elisabeth M. Haberl, Marlen Spirk, Thomas S. Weiss, Reiner Wiest, Christa Buechler. Pentraxin-3 is not related to disease severity in cirrhosis and hepatocellular carcinoma patients. Clinical and Experimental Medicine 2020; 20(2): 289 doi: 10.1007/s10238-020-00617-4
|
3 |
Zongzhang Huang, Qigu Yao, Jianping Zhu, Ying He, Yanghao Chen, Feng Wu, Teng Hua. Efficacy and safety of transjugular intrahepatic portosystemic shunt (TIPS) created using covered stents of different diameters: A systematic review and meta-analysis. Diagnostic and Interventional Imaging 2021; 102(5): 279 doi: 10.1016/j.diii.2020.11.004
|
4 |
Jia-Xing Yang, Yue-Ming Peng, Hao-Tian Zeng, Xi-Min Lin, Zheng-Lei Xu. Drainage of ascites in cirrhosis. World Journal of Hepatology 2024; 16(9): 1245-1257 doi: 10.4254/wjh.v16.i9.1245
|
5 |
Yingying Li, Zuojin Liu, Chang’an Liu. Efficacy and safety of laparoscopic splenectomy for hypersplenism secondary to portal hypertension after transjugular intrahepatic portosystemic shunt. BMC Gastroenterology 2021; 21(1) doi: 10.1186/s12876-021-01647-2
|
6 |
Carolina de la Pinta, Eva Fernández Lizarbe, Ángel Montero Luis, José Antonio Domínguez Rullán, Sonsoles Sancho García. Treatment of symptomatic splenomegaly with low doses of radiotherapy: Retrospective analysis and review of the literature. Technical Innovations & Patient Support in Radiation Oncology 2017; : 23 doi: 10.1016/j.tipsro.2017.08.002
|
7 |
Raj J. Shah, Murad M. Alqadi, Madhavi Duvvuri, Yoon-Jin Kim, Ravi Tyagi, R. Peter Lokken, Ron C. Gaba. Clinical Outcomes and Patency after Transjugular Intrahepatic Portosystemic Shunt Reduction for Overshunting Adverse Events. Journal of Vascular and Interventional Radiology 2022; 33(12): 1507 doi: 10.1016/j.jvir.2022.08.007
|
8 |
Natasha Shah, Rogelio G. Silva, Andrew Kowalski, Chaitanya Desai, Edgar Lerma. Hepatorenal syndrome. Disease-a-Month 2016; 62(10): 364 doi: 10.1016/j.disamonth.2016.05.009
|
9 |
José A. Guirola, Santiago Gil, Luis Zurera, Mikel Echenegusia, Javier Blázquez, Javier Guerrero, José Urbano, Miguel Ángel de Gregorio. Transjugular intrahepatic portosystemic shunt (TIPS) in Spain. Clinical-epidemiological considerations in relation to a multicenter registry. Revista Española de Enfermedades Digestivas 2020; 112 doi: 10.17235/reed.2020.6783/2019
|
10 |
Unai de Andres Olabarria, Soledad Ugarte Sierra, Roberto Maniega Alba, Igor Alberdi San Roman, Francisco Javier Ibáñez Aguirre. Laparoscopic Myotomy After Transjugular Intrahepatic Portosystemic Shunt Placement and Embolization of Gastroesophageal Varices in Patients With Achalasia and Cirrhosis. Cirugía Española (English Edition) 2017; 95(5): 296 doi: 10.1016/j.cireng.2016.10.013
|
11 |
Lauren Shreve, Edward Wolfgang Lee. Role of Interventional Radiology in Complications of Portal Hypertension. Journal of Clinical Gastroenterology 2019; 53(5): 342 doi: 10.1097/MCG.0000000000001180
|
12 |
Nikki Duong, Marcus Healey, Kunal Patel, Brian J Strife, Richard K Sterling. Use of doppler ultrasound to predict need for transjugular intrahepatic portosystemic shunt revision. World Journal of Hepatology 2022; 14(6): 1200-1209 doi: 10.4254/wjh.v14.i6.1200
Abstract(658) |
Core Tip(380) |
Full Article(HTML)(1650)
|
Full Article (PDF)-2181K(156)
|
Full Article (Word)-210K(45)
|
Audio-1467K(6)
|
Peer-Review Report-272K(59)
|
Answering Reviewers-434K(65)
|
Times Cited (0)
|
Total Visits (5761)
|
Open
|
13 |
Syed Mohsin Ali, Shanbin Wu, Hongwei Xu, Hui Liu, Jinghua Hao, Chengyong Qin. A Prospective Study of Endoscopic Injection Sclerotherapy and Endoscopic Variceal Ligation in the Treatment of Esophageal Varices. Journal of Laparoendoscopic & Advanced Surgical Techniques 2017; 27(4): 333 doi: 10.1089/lap.2016.0436
|
14 |
Sebastiano Emanuele Torrisi, Valentin Fuhrmann, Dirk Skowasch, Michael Kreuter. Pulmonary Manifestations of Systemic Diseases. 2019; doi: 10.1183/2312508X.10015119
|
15 |
V. M. Lebezev, G. V. Manukyan, E. E. Fandeev, E. A. Kitsenko, R. A. Musin, E. A. Kosakevich, S. A. Rizaeva, Ya. S. Bobyleva. ”Left gastric vein to inferior vena cava” bypass in patients with portal hypertension. Annaly khirurgicheskoy gepatologii = Annals of HPB Surgery 2020; 25(1): 27 doi: 10.16931/1995-5464.2020127-37
|
16 |
Fuliang He, Shan Dai, Zhibo Xiao, Lei Wang, Zhendong Yue, Hongwei Zhao, Mengfei Zhao, Qiushi Lin, Xiaoqun Dong, Fuquan Liu. Pathological Predictors of Shunt Stenosis and Hepatic Encephalopathy after Transjugular Intrahepatic Portosystemic Shunt. BioMed Research International 2016; 2016: 1 doi: 10.1155/2016/3681731
|
17 |
Francis G. Celii, Jayesh M. Soni, Anil K. Pillai. Liver Diseases. 2020; : 651 doi: 10.1007/978-3-030-24432-3_58
|
18 |
Mihajlo Gjeorgjievski, Mitchell S Cappell. Portal hypertensive gastropathy: A systematic review of the pathophysiology, clinical presentation, natural history and therapy. World Journal of Hepatology 2016; 8(4): 231-262 doi: 10.4254/wjh.v8.i4.231
|
19 |
Guofeng Liu, Xiaoze Wang, Tingting Yang, Yuling Yan, Tong Xiang, Li Yang, Xuefeng Luo. High Interleukin-8 Levels Associated With Decreased Survival in Patients With Cirrhosis Following Transjugular Intrahepatic Portosystemic Shunt. Frontiers in Medicine 2022; 9 doi: 10.3389/fmed.2022.829245
|
20 |
Sukhjeet Singh, Steven M. Hollenberg. Hepatic Critical Care. 2018; : 105 doi: 10.1007/978-3-319-66432-3_9
|
21 |
Song Wang, Mei Xiao, Liqun Hua, Yong Jia, Si Chen, Kaiguang Zhang. Endoscopic therapy for gastro-oesophageal varices of Caroli’s syndrome: a case report. Journal of International Medical Research 2020; 48(2) doi: 10.1177/0300060519877993
|
22 |
Pei-Jing Cui, Jing Yao, Yin Zhu, Zheng-Yun Zhang, Jun Yang. Effects of a Long-Acting Formulation of Octreotide on Patients with Portal Hypertension. Gastroenterology Research and Practice 2017; 2017: 1 doi: 10.1155/2017/3943210
|
23 |
Brian T. Lee, Alexander H. Yang, Seth Urban, Ki-Yoon Kim, Ramon Ter-Oganesyan, Liyun Yuan, Hyosun H. Han, Saro Khemichian, Jeffrey A. Kahn, Brian Kim. Applying the original model for end-stage liver disease score rather than the model for end-stage liver disease-Na score for risk stratification prior to transjugular intrahepatic portosystemic shunt procedures. European Journal of Gastroenterology & Hepatology 2021; 33(4): 541 doi: 10.1097/MEG.0000000000001760
|
24 |
Petre Radu, Virgiliu-Mihail Prunoiu, Victor Strâmbu, Dragos Garofil, Roxana Elena Doncu, Eugen Brătucu, Laurentiu Simion, Maria-Manuela Răvaş, Mircea Nicolae Brătucu, Kevork M. Peltekian. The Portosystemic Shunt for the Control of Variceal Bleeding in Cirrhotic Patients: Past and Present. Canadian Journal of Gastroenterology and Hepatology 2022; 2022: 1 doi: 10.1155/2022/1382556
|
25 |
Israel Grilo-Bensusan, Juan Manuel Pascasio-Acevedo. Hepatopulmonary syndrome: What we know and what we would like to know. World Journal of Gastroenterology 2016; 22(25): 5728-5741 doi: 10.3748/wjg.v22.i25.5728
|
26 |
М. І. Тутченко, С. Л. Чуб, Д. В. Рудик, П. В. Іванчов. КОРЕКЦІЯ ГЕМАТОЛОГІЧНИХ ПОКАЗНИКІВ У ПАЦІЄНТІВ З ПОРТАЛЬНОЮ ГІПЕРТЕНЗІЄЮ. Здобутки клінічної і експериментальної медицини 2023; (3): 165 doi: 10.11603/1811-2471.2023.v.i3.14087
|
27 |
·阿卜拉 阿力木江. Research Progress of Rebleeding with Stent Related Factors after TIPS in Patients with Liver Cirrhosis. Advances in Clinical Medicine 2023; 13(12): 20368 doi: 10.12677/ACM.2023.13122868
|
28 |
|
29 |
Unai de Andres Olabarria, Soledad Ugarte Sierra, Roberto Maniega Alba, Igor Alberdi San Roman, Francisco Javier Ibáñez Aguirre. Miotomía laparoscópica tras derivación portosistémica intrahepática transyugular y embolización de varices gastroesofágicas en paciente con acalasia y cirrosis. Cirugía Española 2017; 95(5): 296 doi: 10.1016/j.ciresp.2016.10.006
|
30 |
Hong-bin Li, Zhen-dong Yue, Hong-wei Zhao, Lei Wang, Zhen-hua Fan, Fu-liang He, Xiao-qun Dong, Fu-quan Liu. Pathological Features of Mitochondrial Ultrastructure Predict Susceptibility to Post-TIPS Hepatic Encephalopathy. Canadian Journal of Gastroenterology and Hepatology 2018; 2018: 1 doi: 10.1155/2018/4671590
|
31 |
Feenalie Patel, Benjamin Bick. Biliary Obstruction After Transjugular Intrahepatic Portosystemic Shunt Placement. ACG Case Reports Journal 2021; 8(6): e00618 doi: 10.14309/crj.0000000000000618
|
32 |
Nobuyuki Toshikuni, Yoshitaka Takuma, Mikihiro Tsutsumi. Management of gastroesophageal varices in cirrhotic patients: current status and future directions. Annals of Hepatology 2016; 15(3): 314 doi: 10.5604/16652681.1198800
|
33 |
Roy U. Bisht, Margaret C. Liu, Jenna E. Koblinski, Paul Kang, Mark N. Wong, Ester C. Little. Is 70 the new 50? Complications and outcomes of transjugular intrahepatic portosystemic shunt in older versus younger patients. Abdominal Radiology 2021; 46(6): 2789 doi: 10.1007/s00261-020-02533-3
|
34 |
Lauren Tal Grinspan, Elizabeth C. Verna. Liver Anesthesiology and Critical Care Medicine. 2018; : 21 doi: 10.1007/978-3-319-64298-7_2
|
35 |
Shanhong Tang, Weizheng Zeng, Jianping Qin, Qianwen He, Xiaoling Wu, Xiaolei Zhou, Zhao Wang, Jianmei Zeng, Zhian Jin, Mingde Jiang. Gastric Variceal Bleeding Caused by an Arterioportal Fistula Formation After TIPS and Related Complications. Digestive Diseases and Sciences 2016; 61(8): 2442 doi: 10.1007/s10620-016-4093-6
|
36 |
Premal S. Trivedi, Matthew A. Brown, Paul J. Rochon, Robert K. Ryu, D. Thor Johnson. Gender Disparity in Inpatient Mortality After Transjugular Intrahepatic Portosystemic Shunt Creation in Patients Admitted With Hepatorenal Syndrome: A Nationwide Study. Journal of the American College of Radiology 2020; 17(2): 231 doi: 10.1016/j.jacr.2019.08.020
|
37 |
Dengke Teng, Hao Zuo, Lin Liu, Jinghui Dong, Lei Ding. Long-term clinical outcomes in patients with viral hepatitis related liver cirrhosis after transjugular intrahepatic portosystemic shunt treatment. Virology Journal 2018; 15(1) doi: 10.1186/s12985-018-1067-7
|
38 |
Damien Leith, Rajeshwar P. Mookerjee. Evidence‐based Gastroenterology and Hepatology 4e. 2019; : 619 doi: 10.1002/9781119211419.ch41
|
39 |
Rakesh K. Varma, Karan Bir Singh, Eric Bready, Deepak Singh, Theresa M. Caridi, Mohamed Shoreibah. LVP vs TIPS for Refractory Ascites: Where Do We Stand?. Digestive Disease Interventions 2022; 6(02): 086 doi: 10.1055/s-0042-1745863
|
40 |
Pan Jiao, Xu-Ying Chen, Hong-Yan Zheng, Jia Qin, Chao Li, Xiao-Lin Zhang. Anticoagulation after transjugular intrahepatic portosystemic shunt for portal hypertension: A systematic review and meta analysis. Medicine 2022; 101(26): e29742 doi: 10.1097/MD.0000000000029742
|
41 |
E. V. Mahiliavets, P. V. Harelik. OPEN ESOPHAGOGASTRIC DEVASCULARIZATION IN ITS OWN MODIFICATION. CASE SERIES PRELIMINARY REPORT. Journal of the Grodno State Medical University 2021; 19(1): 64 doi: 10.25298/2221-8785-2021-19-1-64-70
|
42 |
Keith Pereira, Reginald Baker, Jason Salsamendi, Mehul Doshi, Issam Kably, Shivank Bhatia. An Approach to Endovascular and Percutaneous Management of Transjugular Intrahepatic Portosystemic Shunt (TIPS) Dysfunction: A Pictorial Essay and Clinical Practice Algorithm. CardioVascular and Interventional Radiology 2016; 39(5): 639 doi: 10.1007/s00270-015-1247-4
|
43 |
Zhe Zhang, Xueming Chen, Chenyu Li, Hai Feng, Hongzhi Yu, Renming Zhu, Tianyou Wang. Safety and Efficacy of a Novel Shunt Surgery Combined with Foam Sclerotherapy of Varices for Prehepatic Portal Hypertension: A Pilot Study. Clinics 2019; 74: e704 doi: 10.6061/clinics/2019/e704
|
44 |
Oana Nicoară-Farcău, Ioana Rusu, Horia Stefănescu, Marcel Tanțău, Radu Ion Badea, Bogdan Procopeț. Diagnostic challenges in non-cirrhotic portal hypertension - porto sinusoidal vascular disease. World Journal of Gastroenterology 2020; 26(22): 3000-3011 doi: 10.3748/wjg.v26.i22.3000
|
45 |
Reiner Wiest, Thomas S. Weiss, Lusine Danielyan, Christa Buechler. Serum Amyloid Beta42 Is Not Eliminated by the Cirrhotic Liver: A Pilot Study. Journal of Clinical Medicine 2021; 10(12): 2669 doi: 10.3390/jcm10122669
|
46 |
Avik Majumdar, Giovanni Marasco, Amanda Vestito, Massimo Pinzani, Davide Festi. Elastography of the Liver and Beyond. 2021; : 159 doi: 10.1007/978-3-030-74132-7_11
|